Your browser doesn't support javascript.
loading
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Rosiñol, Laura; Beksac, Meral; Zamagni, Elena; Van de Donk, Niels W C J; Anderson, Kenneth C; Badros, Ashraf; Caers, Jo; Cavo, Michele; Dimopoulos, Meletios-Athanasios; Dispenzieri, Angela; Einsele, Hermann; Engelhardt, Monika; Fernández de Larrea, Carlos; Gahrton, Gösta; Gay, Francesca; Hájek, Roman; Hungria, Vania; Jurczyszyn, Artur; Kröger, Nicolaus; Kyle, Robert A; Leal da Costa, Fernando; Leleu, Xavier; Lentzsch, Suzanne; Mateos, Maria V; Merlini, Giampaolo; Mohty, Mohamad; Moreau, Philippe; Rasche, Leo; Reece, Donna; Sezer, Orhan; Sonneveld, Pieter; Usmani, Saad Z; Vanderkerken, Karin; Vesole, David H; Waage, Anders; Zweegman, Sonja; Richardson, Paul G; Bladé, Joan.
  • Rosiñol L; Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Beksac M; Department of Hematology, Ankara University, Ankara, Turkey.
  • Zamagni E; Istituto di Ematologia "Seràgnoli", Dipartamento di Medicina Specialistica Diagnostica e Sperimentale, Università degli Studi, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Van de Donk NWCJ; Department of Hematology, Amsterdam UMC, VU University, Amsterdam, the Netherlands.
  • Anderson KC; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Badros A; University of Maryland at Baltimore, Baltimore, MD, USA.
  • Caers J; Department of Clinical Hematology, Centre Hospitalier Universitaire de Liège, Liège, Belgium.
  • Cavo M; Istituto di Ematologia "Seràgnoli", Dipartamento di Medicina Specialistica Diagnostica e Sperimentale, Università degli Studi, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Dimopoulos MA; Hematology and Medical Oncology, Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece.
  • Dispenzieri A; Division of Hematology, Mayo Clínic, Rochester, MN, USA.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Engelhardt M; Interdisciplinary Tumor Center, University of Freiburg, Freiburg, Germany.
  • Fernández de Larrea C; Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Gahrton G; Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.
  • Gay F; Myeloma Unit, Città della Salute e della Scienza, University of Torino, Torino, Italy.
  • Hájek R; Department of Haematooncology, University of Ostrava, Ostrava, Czech Republic.
  • Hungria V; Clinica São Germano, São Paulo, Brazil.
  • Jurczyszyn A; Medical College Department of Hematology, Jagiellanian University, Krakow, Poland.
  • Kröger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kyle RA; Division of Hematology, Mayo Clínic, Rochester, MN, USA.
  • Leal da Costa F; Instituto Português de Oncologia, Lisboa, Portugal.
  • Leleu X; Poitiers University Hospital, Poitiers, France.
  • Lentzsch S; Multiple Myeloma and Amyloidosis Service, Columbia University, New York, NY, USA.
  • Mateos MV; IBSAL, Cancer Research Center, University Hospital of Salamanca, Salamanca, Spain.
  • Merlini G; Amyloidosis Research and Treatment Center, Department of molecular Medicine, University of Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Mohty M; Department of Clinical Hematology and Cellular Therapy, Hospital Saint-Antoine, Sorbonne University, París, France.
  • Moreau P; Hematology Department, University Hospital Hotel-Dieu, Nantes, France.
  • Rasche L; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Reece D; Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.
  • Sezer O; Berlín, Germany.
  • Sonneveld P; Erasmus MC Cancer Institute, Erasmus University of Rotterdam, Rotterdam, the Netherlands.
  • Usmani SZ; Department of Hematologic Oncology and Blood Disorders, Levine Cancer institute/Atrium Health, Charlotte, NC, USA.
  • Vanderkerken K; Department Hematology and Immunology, Vriji Universiteit Brussel, Brussels, Belgium.
  • Vesole DH; John Theurer Cancer, Hackensack Meridian School of Medicine, Hackensat, NJ, USA.
  • Waage A; Department of Clinical Molecular Medicine, St. Olavs Hospital, NTNU Trondheim, Trondheim, Norway.
  • Zweegman S; Department of Hematology, Amsterdam UMC, VU University, Amsterdam, the Netherlands.
  • Richardson PG; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Bladé J; Department of Hematology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Br J Haematol ; 194(3): 496-507, 2021 08.
Article en En | MEDLINE | ID: mdl-33724461
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmacitoma / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Plasmacitoma / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article